- Home
- FBNC vs TNDM Comparison
FBNC vs TNDM Comparison
Compare FBNC & TNDM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- FBNC
- TNDM
- Stock Information
- Founded
- FBNC 1934
- TNDM 2006
- Country
- FBNC United States
- TNDM United States
- Employees
- FBNC N/A
- TNDM N/A
- Industry
- FBNC Major Banks
- TNDM Medical/Dental Instruments
- Sector
- FBNC Finance
- TNDM Health Care
- Exchange
- FBNC Nasdaq
- TNDM Nasdaq
- Market Cap
- FBNC 1.7B
- TNDM 1.9B
- IPO Year
- FBNC N/A
- TNDM 2013
- Fundamental
- Price
- FBNC $44.46
- TNDM $35.30
- Analyst Decision
- FBNC Buy
- TNDM Buy
- Analyst Count
- FBNC 1
- TNDM 16
- Target Price
- FBNC $56.00
- TNDM $52.06
- AVG Volume (30 Days)
- FBNC 170.2K
- TNDM 1.1M
- Earning Date
- FBNC 01-27-2025
- TNDM 02-26-2025
- Dividend Yield
- FBNC 1.95%
- TNDM N/A
- EPS Growth
- FBNC N/A
- TNDM N/A
- EPS
- FBNC 2.48
- TNDM N/A
- Revenue
- FBNC $362,644,000.00
- TNDM $854,351,000.00
- Revenue This Year
- FBNC N/A
- TNDM $23.98
- Revenue Next Year
- FBNC $9.87
- TNDM $10.89
- P/E Ratio
- FBNC $18.21
- TNDM N/A
- Revenue Growth
- FBNC N/A
- TNDM 10.75
- 52 Week Low
- FBNC $29.53
- TNDM $21.85
- 52 Week High
- FBNC $50.34
- TNDM $53.69
- Technical
- Relative Strength Index (RSI)
- FBNC 52.03
- TNDM 49.36
- Support Level
- FBNC $43.12
- TNDM $34.33
- Resistance Level
- FBNC $45.00
- TNDM $37.84
- Average True Range (ATR)
- FBNC 1.26
- TNDM 1.81
- MACD
- FBNC 0.21
- TNDM -0.28
- Stochastic Oscillator
- FBNC 71.40
- TNDM 24.56
About FBNC First Bancorp
First Bancorp is a bank holding company. The company is engaged in providing commercial and consumer banking services, mortgage lending, SBA lending, accounts receivable financing, and investment advisory services.
About TNDM Tandem Diabetes Care Inc.
Tandem Diabetes designs, manufactures, and markets durable insulin pumps for diabetes patients. The firm first entered this market in 2012 and has since introduced multiple generations of pumps leading to its current t:slim X2 device. The firm recently launched its smaller Mobi pump and continues to work on a tubeless pump. Nearly three-quarters of total revenue is derived from the us, with the remainder primarily from other developed nations. The pumps themselves generate just over half of total sales, and another one third is from disposable infusion sets that need to be changed over every 2 to 3 days.